Cited by 4,760Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk FactorsCardiovascular Health and Risk Factors

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

Isomaa, Bo, Almgren, Peter, Tuomi, Tiinamaija, Forsén, Björn, Lahti, Kaj, Nissén, Michael, Taskinen, Marja-Riitta, Groop, Leif·2001·Diabetes Care

DOI 10.2337/diacare.24.4.683

Open this paper in CoChat — free account

Abstract

OBJECTIVE—To estimate the prevalence of and the cardiovascular risk associated with the metabolic syndrome using the new definition proposed by the World Health Organization (WHO). RESEARCH DESIGN AND METHODS—A total of 4,483 subjects aged 35–70 years participating in a large family study of type 2 diabetes in Finland and Sweden (the Botnia study) were included in the analysis of cardiovascular risk associated with the metabolic syndrome. In subjects who had type 2 diabetes (n = 1,697), impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) (n = 798), or insulin-resistance with normal glucose tolerance (NGT) (n = 1,988), the metabolic syndrome was defined as presence of at least two of the following risk factors: obesity, hypertension, dyslipidemia, or microalbuminuria. Cardiovascular mortality was assessed in 3,606 subjects with a median follow-up of 6.9 years. RESULTS—In women and men, respectively, the metabolic syndrome was seen in 10 and 15% of subjects with NGT, 42 and 64% of those with IFG/IGT, and 78 and 84% of those with type 2 diabetes. The risk for coronary heart disease and stroke was increased threefold in subjects with the syndrome (P < 0.001). Cardiovascular mortality was markedly increased in subjects with the metabolic syndrome (12.0 vs. 2.2%, P < 0.001). Of the individual components of the metabolic syndrome, microalbuminuria conferred the strongest risk of cardiovascular death (RR 2.80; P = 0.002). CONCLUSIONS—The WHO definition of the metabolic syndrome identifies subjects with increased cardiovascular morbidity and mortality and offers a tool for comparison of results from different studies.

Integrity signals

Registry

Crossref · 10.2337/diacare.24.4.683

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555
Cardiovascular Survey Methods.
Rose, G., & Blackburn, H. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,090
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.-M., & Pająk, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,260
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
The Deadly Quartet
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.7.1514 · Cited by 1,672
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465

Show all 36 references

Research works printed but not linked: 2

Descovich GC, Benassi B, Cancelli V, D’Addato S, De Simone, Dormi A: An epidemic view of the plurimetabolic syndrome. In Diabetes, Obesity and Hyperlipidemias. V. The Plurimetabolic Syndrome Crepaleli G, Tiengo A, Manzato E, Eds. Amsterdam, Netherlands, Elsevier Science, 1993, p. 31–39
Bouchard C, Perusse L: Genetics of causes and manifestations of the metabolic syndrome. In Diabetes, obesity and hyperlipidemia: V. The plurimetabolic syndrome Crepaldi G, Tiengo A, Manzato E, Eds., Amsterdam, Elsevier Science, 1993, p. 67–74

Sorted by citations

Items 501–600 of 1,022

Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy
McCloskey, C. A., Ramani, G. V., Mathier, M. A., Schauer, P. R., Eid, G. M., Mattar, S. G., Courcoulas, A. P., & Ramanathan, R. C. (2007) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2007.05.006 · Cited by 136
Dietary Intake, Eating Habits, and Metabolic Syndrome in Korean Men
Shin, A., Lim, S.-Y., Sung, J., Shin, H.-R., & Kim, J. (2009) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2008.12.015 · Cited by 135
Cinnamon effects on metabolic syndrome: a review based on its mechanisms.
Mollazadeh, H., & Hosseinzadeh, H. (2016) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2016.7906 · Cited by 147
Prevalence of Metabolic Syndrome among Working Adults in Ethiopia
Tran, A. H., Gelaye, B., Girma, B., Lemma, S., Berhane, Y., Bekele, T., Khali, A., & Williams, M. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/193719 · Cited by 134
Enhanced sodium sensitivity and disturbed circadian rhythm of blood pressure in essential hypertension
Uzu, T., Kimura, G., Yamauchi, A., Kanasaki, M., Isshiki, K., Araki, S., Sugiomoto, T., Nishio, Y., Maegawa, H., Koya, D., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000239299.71001.77 · Cited by 135
Obesity, Metabolic Syndrome, and Cardiovascular Disease
Aggoun, Y. (2007) · Pediatric Research · doi:10.1203/pdr.0b013e31805d8a8c · Cited by 135
Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet
Otabe, S., Yuan, X., Fukutani, T., Wada, N., Hashinaga, T., Nakayama, H., Hirota, N., Kojima, M., & Yamada, K. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00645.2006 · Cited by 133
Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis
Zhong, M., Tan, H., Gong, H., Wang, S., Zhang, Y., & Zhang, W. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03248.x · Cited by 131
Bipolar Disorder and the Metabolic Syndrome
Fagiolini, A. M., Chengappa, K. N. R., Soreca, I., & Chang, J. P. (2008) · CNS Drugs · doi:10.2165/00023210-200822080-00004 · Cited by 130
Metabolic Syndrome and Insulin Resistance
Bagry, H., Raghavendran, S., Carli, F., Warner, D. S., & Warner, M. A. A. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181649314 · Cited by 132
Oleuropein: A natural antioxidant molecule in the treatment of metabolic syndrome
Ahamad, J., Toufeeq, I., Khan, M. A., Ameen, M. S. M., Anwer, E. T., Uthirapathy, S., Mir, S. R., & Ahmad, J. (2019) · Phytotherapy Research · doi:10.1002/ptr.6511 · Cited by 140
The prevalence of the metabolic syndrome and type 2 diabetes mellitus in children and adolescents
Molnár, D. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802811 · Cited by 131
Consumption of Sugar-Sweetened Beverages Is Associated with Components of the Metabolic Syndrome in Adolescents
Chan, T., Lin, W., Huang, H., Lee, C., Wu, P., Chiu, Y. W., Huang, C.-C., Tsai, S., Lin, C., & Lin, C. (2014) · Nutrients · doi:10.3390/nu6052088 · Cited by 130
Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes
Okada, H., Fukui, M., Tanaka, M., Inada, S., Mineoka, Y., Nakanishi, N., Senmaru, T., Sakabe, K., Ushigome, E., Asano, M., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.033 · Cited by 130
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients
Leoncini, G., Ratto, E., Viazzi, F. C., VACCARO, V., Parodi, D., Parodi, A., Falqui, V., Tomolillo, C., Deferrari, G., & Pontremoli, R. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01468.x · Cited by 130
The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996–2003
Eliasson, B., Cederholm, J., Nilsson, P. M., & Guðbjörnsdóttir, S. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01648.x · Cited by 128
Management of antipsychotic-related weight gain
Maayan, L. A., & Correll, C. U. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.85 · Cited by 132
Novel Insights in the Metabolic Syndrome in Childhood and Adolescence
Bussler, S., Penke, M., Flemming, G. M. C., Elhassan, Y., Kratzsch, J., Sergeyev, E., Lipek, T., Vogel, M., Spielau, U., Körner, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479510 · Cited by 143
Insulin resistance and clinical outcomes after acute ischemic stroke
Ago, T., Matsuo, R., Hata, J., Wakisaka, Y., Kuroda, J., Kitazono, T., Kamouchi, M., & On behalf of the Fukuoka Stroke Registry Investigators (2018) · Neurology · doi:10.1212/wnl.0000000000005358 · Cited by 135
Impact of Ramadan diurnal intermittent fasting on the metabolic syndrome components in healthy, non-athletic Muslim people aged over 15 years: a systematic review and meta-analysis
Faris, M. E., Jahrami, H., Alsibai, J., & Obaideen, A. A. (2019) · British Journal Of Nutrition · doi:10.1017/s000711451900254x · Cited by 129
The central role of fat and effect of peroxisome proliferator-activated receptor–γ on progression of insulin resistance and cardiovascular disease
Hsueh, W. A., & Law, R. E. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00610-6 · Cited by 129
The Usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III Definitions of the Metabolic Syndrome in Predicting Coronary Heart Disease in Subjects With Type 2 Diabetes
Tong, P. C. Y., Kong, A. P. S., So, W., Yang, X., Ho, C. S., Ronald, C. W., Ozaki, R., Chow, C., Lam, C. W. K., Chan, J. C. N., et al. (2007) · Diabetes Care · doi:10.2337/dc06-1484 · Cited by 129
Cardiorespiratory fitness and the metabolic syndrome in firefighters
Donovan, R., Nelson, T. L., Peel, J. L., Lipsey, T., Voyles, W. F., & Israel, R. G. (2009) · Occupational Medicine · doi:10.1093/occmed/kqp095 · Cited by 128
Measures of adiposity in the identification of metabolic abnormalities in elderly men
Wannamethee, S. G., Shaper, A. G., Morris, R. W., & Whincup, P. H. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.6.1313 · Cited by 126
Metabolic syndrome: what are the risks for humans?
Gupta, A. K., & Gupta, V. (2010) · PubMed · Cited by 128
In Vivo Actions of Peroxisome Proliferator–Activated Receptors
Eldor, R., DeFronzo, R. A., & Abdul‐Ghani, M. A. (2013) · Diabetes Care · doi:10.2337/dcs13-2003 · Cited by 128
A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans
Yi, M., Li, H., Wu, Z., Yan, J., Liu, Q., Ou, C., & Chen, M. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000486225 · Cited by 129
Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat
Park, S., Farooq, M. A., Gaertner, S., Bruckert, C., Qureshi, A. W., Lee, H.-H., Benrahla, D., Pollet, B., Stéphan, D., Ohlmann, P., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-00997-7 · Cited by 129
Inflammation in Diabetes Mellitus: Role of Peroxisome Proliferator-Activated Receptor–α and Peroxisome Proliferator-Activated Receptor–γ Agonists
Libby, P., & Plutzky, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.004 · Cited by 128
Effects of a lifestyle modification program in HIV-infected patients with the metabolic syndrome
Fitch, K. V., Anderson, E. J., Hubbard, J. L., Carpenter, S. J., Waddell, W. R., Caliendo, A. M., & Grinspoon, S. K. (2006) · AIDS · doi:10.1097/01.aids.0000244203.95758.db · Cited by 127
Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition
Harwood, H. J., Jr. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.2.267 · Cited by 129
Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans
Yun, K. E., Shin, C. Y., Yoon, Y. S., & Park, H. S. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.012 · Cited by 128
Gordura visceral e síndrome metabólica: mais que uma simples associação
Filho, F. F. R., Mariosa, L. S. S., Ferreira, S. R. G., & Zanella, M. T. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200009 · Cited by 132
Association between diet-related inflammation, all-cause, all-cancer, and cardiovascular disease mortality, with special focus on prediabetics: findings from NHANES III
Deng, F. E., Shivappa, N., Tang, Y., Mann, J. R., & Hébert, J. R. (2016) · European Journal of Nutrition · doi:10.1007/s00394-016-1158-4 · Cited by 128
Obesity and non-alcoholic fatty liver disease: Disparate associations among Asian populations
Wong, R. J. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i5.263 · Cited by 127
Reduction of Visceral Fat Is Associated With Decrease in the Number of Metabolic Risk Factors in Japanese Men
Okauchi, Y., Nishizawa, H., Funahashi, T., Ogawa, T., Noguchi, M., Ryo, M., Kihara, S., Iwahashi, H., Yamagata, K., Nakamura, T., et al. (2007) · Diabetes Care · doi:10.2337/dc07-0218 · Cited by 126
Stressful Life Events and the Metabolic Syndrome
Pyykkönen, A.-J., Räikkönen, K., Tuomilehto, J., Eriksson, J. G., Groop, L., & Isomaa, B. (2009) · Diabetes Care · doi:10.2337/dc09-1027 · Cited by 131
Self-citation
Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease
Poulain, M., Doucet, M., Drapeau, V., Fournier, G., Tremblay, A., Poirier, P., & Maltais, F. (2008) · Chronic Respiratory Disease · doi:10.1177/1479972307087205 · Cited by 129
Identification of Subjects with Insulin Resistance and β-Cell Dysfunction Using Alternative Definitions of the Metabolic Syndrome
Hanley, A. J., Wagenknecht, L. E., D’Agostino, R. B., Zinman, B., & Haffner, S. M. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2740 · Cited by 125
Plant-based diets and incident metabolic syndrome: Results from a South Korean prospective cohort study
Kim, H., Lee, K., Rebholz, C. M., & Kim, J. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003371 · Cited by 125
Insulin resistance – a common link between type 2 diabetes and cardiovascular disease
Lebovitz, H. E. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00521.x · Cited by 125
Omega-3 and omega-6 polyunsaturated fatty acids and metabolic syndrome: A systematic review and meta-analysis
Jang, H., & Park, K. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.03.032 · Cited by 131
Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus
Fukui, M., Tanaka, M., Shiraishi, E., Harusato, I., Hosoda, H., Asano, M., Kadono, M., Hasegawa, G., Yoshikawa, T., & Nakamura, N. (2008) · Metabolism · doi:10.1016/j.metabol.2007.12.005 · Cited by 123
Components of the Metabolic Syndrome and Risk for First-Ever Acute Ischemic Nonembolic Stroke in Elderly Subjects
Milionis, H. J., Rizos, E. C., Goudevenos, J. A., Seferiadis, K. I., Mikhailidis, D. P., & Elisaf, M. (2005) · Stroke · doi:10.1161/01.str.0000169935.35394.38 · Cited by 120
Low Ankle-Brachial Pressure Index Predicts Increased Risk of Cardiovascular Disease Independent of the Metabolic Syndrome and Conventional Cardiovascular Risk Factors in the Edinburgh Artery Study
Wild, S. H., Byrne, C. D., Smith, F. B., Lee, A. J., & Fowkes, F. G. R. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-1637 · Cited by 123
Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes
Fukui, M., Tanaka, M., Shiraishi, E., Harusato, I., Hosoda, H., Asano, M., Hasegawa, G., & Nakamura, N. (2008) · Kidney International · doi:10.1038/ki.2008.398 · Cited by 122
(Mis)use of Factor Analysis in the Study of Insulin Resistance Syndrome
Lawlor, D. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh150 · Cited by 122
The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women
Royer, M., Castelo‐Branco, C., Blümel, J. E., Chedraui, P. A., Danckers, L., Bencosme, A., Navarro, D., Vallejo, S., Espinoza, M. T., Gómez, G., et al. (2007) · Climacteric · doi:10.1080/13697130701258895 · Cited by 122
White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging
Alfaro, F. J., Gavrieli, A., Saade-Lemus, P., Lioutas, V., Upadhyay, J., & Novak, V. (2017) · Metabolism · doi:10.1016/j.metabol.2017.08.009 · Cited by 125
Metabolic Syndrome and Early-Onset Coronary Artery Disease
Iribarren, C., Go, A. S., Husson, G., Sidney, S. S., Fair, J. M., Quertermous, T., Hlatky, M. A., & Fortmann, S. P. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.070 · Cited by 121
Stroke in patients with diabetes mellitus
Mankovsky, B., & Ziegler, D. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.490 · Cited by 123
Metabolic Syndrome in Rheumatoid Arthritis
Ferraz‐Amaro, I., González‐Juanatey, C., López‐Mejías, R., Riancho‐Zarrabeitia, L., & González-Gay, M. Á. (2013) · Mediators of Inflammation · doi:10.1155/2013/710928 · Cited by 121
The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
Benetti, E., Chiazza, F., Patel, N. S. A., & Collino, M. (2013) · Mediators of Inflammation · doi:10.1155/2013/678627 · Cited by 122
Organosulfur compounds and cardiovascular disease
Prieto, M. A. V., & Miatello, R. M. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.09.009 · Cited by 120
Antihypertensive and Angiotensin-I-Converting Enzyme (ACE)-Inhibitory Peptides from Fish as Potential Cardioprotective Compounds
Abachi, S., Bazinet, L., & Beaulieu, L. (2019) · Marine Drugs · doi:10.3390/md17110613 · Cited by 122
Metabolic Syndrome, Obesity, and Related Risk Factors Among College Men and Women
Morrell, J. S., Lofgren, I. E., Burke, J. D., & Reilly, R. A. (2011) · Journal of American College Health · doi:10.1080/07448481.2011.582208 · Cited by 125
The Association Between Sleep and Metabolic Syndrome: A Systematic Review and Meta-Analysis
Che, T., Cheng, Y. Z., Tian, D., Zhang, X., Liu, X., & Wu, Z. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.773646 · Cited by 128
Epidemiology and treatment of the metabolic syndrome
Laaksonen, D. E., NISKANEN, L. K., Lakka, H., Lakka, T. A., & Uusitupa, M. I. J. (2004) · Annals of Medicine · doi:10.1080/07853890410031849 · Cited by 121
Obstructive sleep apnea: An update on mechanisms and cardiovascular consequences
Wolf, J., Lewicka, J., & Narkiewicz, K. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.12.005 · Cited by 121
Antidepressant drugs and cardiovascular pathology: a clinical overview of effectiveness and safety
Taylor, D. M. (2008) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01260.x · Cited by 120
Hyperglycemia and cardiovascular disease
Duckworth, W. C. (2001) · Current Atherosclerosis Reports · doi:10.1007/s11883-001-0076-x · Cited by 119
The prevalence of metabolic syndrome in patients with bipolar disorder
García‐Portilla, M. P., Sáiz, P. A., Benabarre, A., Sierra, P., Pérez‐Blanco, J., Rodriguez, A., Livianos, L., Torres, P., & Bobes, J. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.06.002 · Cited by 119
Mitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches
Sanchis‐Gomar, F., García‐Giménez, J. L., Gómez‐Cabrera, M. C., & Pallardó, F. V. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140306095106 · Cited by 120
Pentacyclic triterpenes: New tools to fight metabolic syndrome
Sharma, H., Kumar, P., Deshmukh, R. R., Bishayee, A., & Kumar, S. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.011 · Cited by 118
Obesity is Associated with Worsening Cardiovascular Risk Factor Profiles and Proteinuria Progression in Renal Transplant Recipients
Armstrong, K. A., Campbell, S. B., Hawley, C. M., Nicol, D. L., Johnson, D. W., & Isbel, N. M. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01073.x · Cited by 118
Studies of the Pro12Ala Polymorphism of the PPAR-γ Gene in the Danish MONICA Cohort: Homozygosity of the Ala Allele Confers a Decreased Risk of the Insulin Resistance Syndrome
Frederiksen, L., Brødbæk, K., Fenger, M., Jørgensen, T., Borch‐Johnsen, K., Madsbad, S., & Urhammer, S. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8732 · Cited by 118
High-sensitive C-reactive protein, tumor necrosis factor α, and cardiovascular risk factors before and after weight loss in obese children
Reinehr, T., Stoffel‐Wagner, B., Roth, C. L., & Andler, W. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.022 · Cited by 119
Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome
Laaksonen, D. E., Toppinen, L., Juntunen, K. S., Autio, K., Liukkonen, K. H., Poutanen, K. S., NISKANEN, L. K., & Mykkänen, H. M. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.6.1218 · Cited by 119
Rimonabant: A Cannabinoid Receptor Type 1 Blocker for Management of Multiple Cardiometabolic Risk Factors
Gelfand, E. V., & Cannon, C. P. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.067 · Cited by 118
Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women
Torréns, J. I., Sutton-Tyrrell, K., Zhao, X., Matthews, K. A., Brockwell, S. E., Sowers, M. R., & Santoro, N. (2009) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e318185e249 · Cited by 117
Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification
Johnson, D. W., Armstrong, K. A., Campbell, S. B., Mudge, D. W., Hawley, C. M., Coombes, J. S., Prins, J. B., & Isbel, N. M. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00804.x · Cited by 117
The evolution of body fatness: trading off disease and predation risk
Speakman, J. R. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.167254 · Cited by 123
A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin
Jansson, P., Pellmé, F., Hammarstedt, A., Sandqvist, M., Brekke, H. K., Caidahl, K., Forsberg, M., Volkmann, R., Carvalho, E., Funahashi, T., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1132com · Cited by 116
Self-citation
Nanoparticles That Sense Thrombin Activity As Synthetic Urinary Biomarkers of Thrombosis
Lin, K., Kwong, G. A., Warren, A., Wood, D. K., & Bhatia, S. N. (2013) · ACS Nano · doi:10.1021/nn403550c · Cited by 118
All-Cause Mortality Associated With Specific Combinations of the Metabolic Syndrome According to Recent Definitions
Guize, L., Thomas, F., Pannier, B., Bean, K., Jégo, B., & Bénétos, A. (2007) · Diabetes Care · doi:10.2337/dc07-0186 · Cited by 117
Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria
Yusuff, K. B., Obe, O., & Joseph, B. Y. (2008) · Pharmacy World & Science · doi:10.1007/s11096-008-9243-2 · Cited by 118
A systematic review, meta-analysis, and meta-regression of the impact of diurnal intermittent fasting during Ramadan on body weight in healthy subjects aged 16 years and above
Jahrami, H., Alsibai, J., Clark, C. C. T., & Faris, M. E. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02216-1 · Cited by 116
Obesity‐related Changes in High‐density Lipoprotein Metabolism
Mooradian, A. D., Haas, M. J., Wehmeier, K. R., & Wong, N. C. W. (2008) · Obesity · doi:10.1038/oby.2008.202 · Cited by 115
An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies
Singh, S., Young, P. M., & Armstrong, A. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181039 · Cited by 115
Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights
Jia, G., Bai, H., Mather, B., Hill, M. A., Jia, G., & Sowers, J. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020804 · Cited by 127
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
Fagerberg, B., Edwards, S., Halmos, T., Łopatyński, J., Schuster, H., Stender, S., Birketvedt, G. S., Tonstad, S., Halldórsdóttir, S., & Gause‐Nilsson, I. A. M. (2005) · Diabetologia · doi:10.1007/s00125-005-1846-8 · Cited by 115
The 2005 Dietary Guidelines for Americans and risk of the metabolic syndrome
Fogli-Cawley, J. J., Dwyer, J. T., Saltzman, E. J., McCullough, M. L., Troy, L. M., Meigs, J. B., & Jacques, P. F. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.4.1193 · Cited by 114
Association Between Serum Testosterone Concentration and Carotid Atherosclerosis in Men With Type 2 Diabetes
Fukui, M., Kitagawa, Y., Nakamura, N., Kadono, M., Mogami, S.-I., Hirata, C., Ichio, N., Wada, K., Hasegawa, G., & Yoshikawa, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1869 · Cited by 114
Prevalence of Metabolic Syndrome in the Mediterranean Region of Turkey: Evaluation of Hypertension, Diabetes Mellitus, Obesity, and Dyslipidemia
Gündoğan, K., Bayram, F., Capak, M., Tanrıverdi, F., Karaman, A., Öztürk, A., Altunbaş, H., Gökçe, C., Kalkan, A. K., & Yazıcı, C. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0068 · Cited by 114
Fatty acids and the metabolic syndrome
Roche, H. M. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2004405 · Cited by 113
RELATIONSHIP BETWEEN ADIPOKINES, INFLAMMATION, AND VASCULAR REACTIVITY IN LEAN CONTROLS AND OBESE SUBJECTS WITH METABOLIC SYNDROME
Bahia, L., Kraemer‐Aguiar, L. G., Villela, N. R., Bottino, D. A., Godoy‐Matos, A. F., Geloneze, B., Tambascia, M. A., & Bouskela, E. (2006) · Clinics · doi:10.1590/s1807-59322006000500010 · Cited by 112
The Inflamed Liver and Atherosclerosis: A Link Between Histologic Severity of Nonalcoholic Fatty Liver Disease and Increased Cardiovascular Risk
Alkhouri, N., Tamimi, T., Yerian, L. M., López, R., Zein, N. N., & Feldstein, A. E. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1075-y · Cited by 116
Metabolic Syndrome and Diabetes Are Associated With an Increased Likelihood of Inducible Myocardial Ischemia Among Patients With Subclinical Atherosclerosis
Wong, N. D., Rozanski, A., Gransar, H., Miranda-Peats, R., Kang, X., Hayes, S. W., Shaw, L. J., Friedman, J. D., Polk, D. M., & Berman, D. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1445 · Cited by 113
A Phenomics-Based Strategy Identifies Loci on APOC1, BRAP, and PLCG1 Associated with Metabolic Syndrome Phenotype Domains
Avery, C. L., He, Q., North, K. E., Ambite, J. L., Boerwinkle, E., Fornage, M., Hindorff, L. A., Kooperberg, C. L., Meigs, J. B., Pankow, J. S., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002322 · Cited by 113
Relationship of Metabolic Syndrome With Incident Aortic Valve Calcium and Aortic Valve Calcium Progression
Katz, R., Budoff, M. J., Takasu, J., Shavelle, D. M., Bertoni, A. G., Blumenthal, R. S., Ouyang, P., Wong, N. D., & O’Brien, K. D. (2009) · Diabetes · doi:10.2337/db08-1515 · Cited by 116
Effects of VLDL and remnant particles on platelets.
Olufadi, R., & Byrne, C. D. (2006) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000093221 · Cited by 111
Is oxidative stress of adipocytes a cause or a consequence of the metabolic syndrome?
Маслов, Л. Н., Naryzhnaya, N. V., Boshchenko, A. A., Popov, S. V., Ivanov, V. V., & Oeltgen, P. R. (2018) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2018.11.001 · Cited by 111
Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects
Kim, B., Kim, T. Y., Koh, J., Kim, H. K., Park, J., Lee, K., Shong, Y. K., & Kim, W. B. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03304.x · Cited by 111
Epidemiology of the Metabolic Syndrome
Reynolds, K., & He, J. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00004 · Cited by 111
Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies
Bunn, F., Kirby, M. G., Pinkney, E., Cardozo, L., Chapple, C. R., Chester, K., Cruz, F., Haab, F., Kelleher, C. J., Milsom, I., et al. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12518 · Cited by 115
The effects of whey protein on cardiometabolic risk factors
Pal, S., & Radavelli‐Bagatini, S. (2012) · Obesity Reviews · doi:10.1111/obr.12005 · Cited by 111
Incident Coronary Heart Disease After Preeclampsia: Role of Reduced Fetal Growth, Preterm Delivery, and Parity
Riise, H. K. R., Sulo, G., Tell, G. S., Igland, J., Nygard, O. K., Vollset, S. E., Iversen, A., Austgulen, R., & Daltveit, A. K. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004158 · Cited by 110
The Metabolic Syndrome in Patients With Severe Mental Illnesses
Toalson, P. A., Ahmed, S., Hardy, T. A., & Kabinoff, G. S. (2004) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.v06n0402 · Cited by 106
Development of Diabetes in Chinese With the Metabolic Syndrome
Cheung, B. M. Y., Wat, N. M. S., Man, Y. B., Tam, S., Thomas, G. N., Leung, G. M., Cheng, C. H., Woo, J., Janus, E. D., Lau, C., et al. (2007) · Diabetes Care · doi:10.2337/dc06-1820 · Cited by 109
Mesenteric Fat Thickness Is an Independent Determinant of Metabolic Syndrome and Identifies Subjects With Increased Carotid Intima-Media Thickness
Liu, K. H., Chan, Y. L., Chan, W. B., Chan, J. C. N., & Chu, C. W. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1578 · Cited by 108

Authors: Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L.
Affiliations: Department of Internal Medicine, Jakobstad Hospital, Jakobstad, Finland
Lund University (SE)
Helsinki University Hospital (FI)
Närpes Health Center, Närpes
Vasa Health Center
Vaasa Central Hospital (FI)
ORCID: Almgren, Peter
Taskinen, Marja-Riitta
Groop, Leif
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2001-04-01
Volume: 24
Issue: 4
Pages: 683-689
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.24.4.683
OpenAlex: W1986349550
Cited by: 4,760
References: 36
Citations by year: 2026: 27 · 2025: 70 · 2024: 93 · 2023: 88 · 2022: 123 · 2021: 132 · 2020: 128 · 2019: 137 · 2018: 139 · 2017: 153 · 2016: 185 · 2015: 198 · 2014: 218 · 2013: 211 · 2012: 222
FWCI: 100.87
Type: journal article
Language: en
Open access: closed
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Lund University Publications (Lund University) (submittedVersion)
Funders: Svenska Läkaresällskapet
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords: metabolic syndrome, cardiovascular mortality, cardiovascular morbidity, type 2 diabetes, impaired fasting glucose, impaired glucose tolerance, insulin resistance, microalbuminuria, coronary artery disease, stroke, obesity, hypertension, dyslipidemia, WHO definition
MeSH terms: Adult, Age Factors, Aged, Albuminuria, Blood Glucose, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Type 2, Family, Female, Finland, Glycated Hemoglobin, Humans, Hyperlipidemias, Hypertension, Insulin Resistance, Cholesterol, HDL, Male, Middle Aged, Morbidity, Obesity, Risk Factors, Sex Factors, Sweden, Triglycerides, Prevalence, Glucose Intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks